Literature DB >> 17055152

Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1.

David Kessel1, John J Reiners.   

Abstract

L1210 murine leukemia cells exposed to an LD(90) concentration of the Bcl-2/Bcl-x(L) antagonist HA14-1 rapidly undergo apoptosis but also develop numerous intracellular vacuoles with double membranes, exhibit enhanced labeling by monodansylcadaverine, and convert the cytosolic protein LC3-I to LC3-II. These are hallmarks of autophagy. Autophagic vacuoles develop rapidly, preceding the appearance of an apoptotic nuclear morphology and can be observed in both non-apoptotic and apoptotic cells. Inhibition of autophagy by the PI 3-kinase inhibitor wortmannin promoted apoptosis; conversely inhibition of caspase-3/7 with zDEVD-fmk promoted autophagy. Neither process was dependent on calcium translocation. These results indicate that pharmacological suppression of Bcl-2 function can mimic the induction of autophagy that can occur following the down-regulation of Bcl-2 expression by molecular approaches.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055152      PMCID: PMC1924967          DOI: 10.1016/j.canlet.2006.09.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  21 in total

Review 1.  Autophagy: molecular machinery for self-eating.

Authors:  T Yorimitsu; D J Klionsky
Journal:  Cell Death Differ       Date:  2005-11       Impact factor: 15.828

2.  Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy.

Authors:  Sophie Pattingre; Amina Tassa; Xueping Qu; Rita Garuti; Xiao Huan Liang; Noboru Mizushima; Milton Packer; Michael D Schneider; Beth Levine
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

Review 3.  Autophagy in cell death: an innocent convict?

Authors:  Beth Levine; Junying Yuan
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

4.  Initiation of apoptosis and autophagy by photodynamic therapy.

Authors:  David Kessel; M Graça H Vicente; John J Reiners
Journal:  Lasers Surg Med       Date:  2006-06       Impact factor: 4.025

5.  Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy.

Authors:  Isei Tanida; Naoko Minematsu-Ikeguchi; Takashi Ueno; Eiki Kominami
Journal:  Autophagy       Date:  2005-07-31       Impact factor: 16.016

Review 6.  Bcl-2 inhibition of autophagy: a new route to cancer?

Authors:  Sophie Pattingre; Beth Levine
Journal:  Cancer Res       Date:  2006-03-15       Impact factor: 12.701

7.  Apoptotic response to photodynamic therapy versus the Bcl-2 antagonist HA14-1.

Authors:  David Kessel; Michelle Castelli; John J Reiners
Journal:  Photochem Photobiol       Date:  2002-09       Impact factor: 3.421

8.  Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4.

Authors:  L Y Xue ; S M Chiu ; N L Oleinick
Journal:  Oncogene       Date:  2001-06-07       Impact factor: 9.867

9.  Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells.

Authors:  J L Wang; D Liu; Z J Zhang; S Shan; X Han; S M Srinivasula; C M Croce; E S Alnemri; Z Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

10.  Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells.

Authors:  K Saeki; A Yuo; E Okuma; Y Yazaki; S A Susin; G Kroemer; F Takaku
Journal:  Cell Death Differ       Date:  2000-12       Impact factor: 15.828

View more
  18 in total

1.  Apoptotic and autophagic responses to Bcl-2 inhibition and photodamage.

Authors:  David Kessel; Adelaida Segarra Arroyo
Journal:  Photochem Photobiol Sci       Date:  2007-07-30       Impact factor: 3.982

2.  Promotion of PDT efficacy by a Bcl-2 antagonist.

Authors:  David Kessel
Journal:  Photochem Photobiol       Date:  2007-12-20       Impact factor: 3.421

Review 3.  Therapeutic targeting of autophagy in disease: biology and pharmacology.

Authors:  Yan Cheng; Xingcong Ren; William N Hait; Jin-Ming Yang
Journal:  Pharmacol Rev       Date:  2013-08-13       Impact factor: 25.468

Review 4.  Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy?

Authors:  V Labi; F Grespi; F Baumgartner; A Villunger
Journal:  Cell Death Differ       Date:  2008-03-28       Impact factor: 15.828

Review 5.  Autophagy modulation for cancer therapy.

Authors:  Zhineng J Yang; Cheng E Chee; Shengbing Huang; Frank Sinicrope
Journal:  Cancer Biol Ther       Date:  2011-01-15       Impact factor: 4.742

Review 6.  Stimulation of anti-tumor immunity by photodynamic therapy.

Authors:  Pawel Mroz; Javad T Hashmi; Ying-Ying Huang; Norbert Lange; Michael R Hamblin
Journal:  Expert Rev Clin Immunol       Date:  2011-01       Impact factor: 4.473

7.  Apoptosis of t(14;18)-positive lymphoma cells by a Bcl-2 interacting small molecule.

Authors:  David R Abbott; Robert T Abbott; Stephen D Jenson; G Chris Fillmore; Kojo S J Elenitoba-Johnson; Megan S Lim
Journal:  J Hematop       Date:  2009-02-28       Impact factor: 0.196

8.  PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.

Authors:  Imran Rizvi; Sriram Anbil; Nermina Alagic; Jonathan Celli; Jonathan P Celli; Lei Zak Zheng; Akilan Palanisami; Michael D Glidden; Brian W Pogue; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2013-04-04       Impact factor: 3.421

9.  Apoptosis and autophagy after mitochondrial or endoplasmic reticulum photodamage.

Authors:  David Kessel; John J Reiners
Journal:  Photochem Photobiol       Date:  2007 Sep-Oct       Impact factor: 3.421

10.  Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis.

Authors:  Anatasha C Crawford; Rebecca B Riggins; Ayesha N Shajahan; Alan Zwart; Robert Clarke
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.